Stocks
Teladoc Health (TDOC) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 633.4% | 487.8% | 193.1% | 222.9% | 253.6% | ||||
| Changes by years, y/y, % | +40pp | -633pp | -295pp | +30pp | -19.2% | ||||
Teladoc Health. R&D/CAPEX, %
Teladoc Health. R&D/CAPEX, changes, pp
Teladoc Health (TDOC) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q4 | 2024Q1 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| R&D/CAPEX, % | 246.4% | 7 083% | 229.2% | 276.6% | 123.5% | 253.6% | ||
| Changes by years, y/y, % | +92pp | +6 893pp | +39pp | +38pp | -100pp | |||
| Changes by quarters, q/q, % | +22pp | +6 837pp | -6 854pp | +47pp | -153pp | |||
